Skip to content

Clinical trials

Phase 1 Pulmonary Disease, Chronic Obstructive trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 1 Country / region: China Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20161
20173
20181
20212
20221
20233
20247
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status4
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.6
Guangdong Hengrui Pharmaceutical Co., Ltd3
GlaxoSmithKline2
Joincare Pharmaceutical Group Industry Co., Ltd2
Mabwell (Shanghai) Bioscience Co., Ltd.2
Anhui Hemay Pharmaceutical Co., Ltd1
AstraZeneca1
Bambusa Therapeutics1
Boehringer Ingelheim1
Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive27
Asthma4
Dermatitis, Atopic2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.